Association between Gene Expression Profile, Proliferation and Metastasis in Uveal Melanoma

被引:27
作者
Onken, Michael D. [1 ]
Worley, Lori A. [1 ]
Harbour, J. William [1 ]
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
关键词
Choroid; Ciliary body; Eye; Gene expression profile; Metastasis; Proliferation; Survival; Uveal melanoma; MICROCIRCULATION PATTERNS; CILIARY BODY; KI-67; IMMUNOREACTIVITY; IRIS;
D O I
10.3109/02713683.2010.493265
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: Uveal melanomas cluster into two molecular groups based on their gene expression profile. Tumors with the class 1 signature rarely metastasize, whereas those with the class 2 signature have a very high rate of metastasis. However, the biological basis for this metastatic propensity of class 2 tumors remains unclear. Towards such an explanation, this study was conducted to determine whether class 2 tumors have a higher proliferative rate than class 1 tumors. Materials and Methods: The study included 28 primary uveal melanomas with extensive clinical, pathologic, and genetic annotation, including age, gender, ciliary body involvement, tumor basal diameter, thickness, cell type, gene expression profile, status of chromosomes 3 and 8p, aneuploidy, and clinical outcome. Immunopositivity for Ki-67 was determined by counting all positive nuclei in representative whole tumor sections. Results: Ki-67 positivity was significantly associated with class 2 gene expression profile, loss of chromosome 3 and increased aneuploidy (P=0.04, P=0.004, and P=0.03, respectively). Ki-67 positivity showed a borderline significant association with epithelioid cell type (P=0.07). Receiver operating characteristic (ROC) analysis of Ki-67 positivity, using the class 2 signature as an endpoint, identified a Ki-67 score of approximately 20 cells per high power field as the optimal cut-off point between low and high risk for metastasis (log rank test, P=0.01). Conclusions: On average, class 2 uveal melanomas have a higher proliferative rate than class 1 tumors. Further work is needed to determine whether loss of chromosome 3, increased aneuploidy, or other factors may be responsible for the increased proliferation.
引用
收藏
页码:857 / 863
页数:7
相关论文
共 18 条
[1]   KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors [J].
Al-Jamal, RT ;
Kivelä, T .
CURRENT EYE RESEARCH, 2006, 31 (01) :57-67
[2]   KI-67 AND BROMODEOXYURIDINE LABELING OF HUMAN CHOROIDAL MELANOMA-CELLS [J].
BARDENSTEIN, DS ;
CHAR, DH ;
KALETAMICHAELS, S ;
KROLL, SM .
CURRENT EYE RESEARCH, 1991, 10 (05) :479-484
[3]   A 3-dB quadrature coupler using broadside-coupled coplanar waveguides [J].
Chang, Chieh-Plin ;
Chiu, Jui-Chieh ;
Chiu, Hua-Yueh ;
Wang, Yeong-Her .
IEEE MICROWAVE AND WIRELESS COMPONENTS LETTERS, 2008, 18 (03) :191-193
[4]   P53 Immunoreactivity, Ki-67 expression, and microcirculation patterns in melanoma of the iris, ciliary body, and choroid [J].
Chowers, I ;
Folberg, R ;
Livni, N ;
Pe'er, J .
CURRENT EYE RESEARCH, 2002, 24 (02) :105-108
[5]   Comparison of microcirculation patterns and MIB-1 immunoreactivity in iris and posterior uveal melanoma [J].
Chowers, I ;
Folberg, R ;
Livni, N ;
Pe'er, J .
OPHTHALMOLOGY, 2001, 108 (02) :367-371
[6]   Integrative genomic analysis of aneuploidy in uveal melanoma [J].
Ehlers, Justis P. ;
Worley, Lori ;
Onken, Michael D. ;
Harbour, J. William .
CLINICAL CANCER RESEARCH, 2008, 14 (01) :115-122
[7]   PRODUCTION OF A MOUSE MONOCLONAL-ANTIBODY REACTIVE WITH A HUMAN NUCLEAR ANTIGEN ASSOCIATED WITH CELL-PROLIFERATION [J].
GERDES, J ;
SCHWAB, U ;
LEMKE, H ;
STEIN, H .
INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (01) :13-20
[8]   Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma [J].
Karlsson, M ;
Boeryd, B ;
Carstensen, J ;
Franlund, B ;
Gustafsson, B ;
Kagedal, B ;
Sun, XF ;
Wingren, S .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (02) :357-362
[9]   Cell cycle, CDKs and cancer: a changing paradigm [J].
Malumbres, Marcos ;
Barbacid, Mariano .
NATURE REVIEWS CANCER, 2009, 9 (03) :153-166
[10]  
MOOY CM, 1990, OPHTHALMOLOGY, V97, P1275